EN >
+34 680 260 118
EN >
medmesafe
EN >
Services
You will receive an e-mail with instructions to reset your password
Hereditary cancers
Screening for risks of the following cancers: breast, ovarian, prostate, pancreatic, stomach, colorectal and skin.
This study interprets your genes to determine the risk you have to suffer from different
types of cancer of hereditary character. It provides you with key information so that you
can take preventive and/or follow-up measures to reduce your risk of developing the disease or detect it early.
1/6
One in six deaths worldwide
is due to cancer, according to 2017 data.(1)
90%
Early detection of breast cancer
ensures 90% survival.(2)
5-10%
It is estimated that between 5-10% of cancer cases have a hereditary component,
reaching 20% in certain types of cancer.(3)
25%
About 25% of hereditary breast and ovarian cancer cases
are due to mutations in the BRCA1 and BRCA2 genes.(4)
(1) Source: ourworldindata
(2) Source: Asociación española contra el cáncer.
(3) Source: SEOM (Sociedad Española de Oncología Médica).
(4) Source: Nielsen FC et al. Nature Reviews. 2016;16:599-612
Hereditary cancers
- Study the following hereditary cancer syndromes:
- Lynch Syndrome
- Gorlin Syndrome
- Birt-Hogg-Dube Syndrome
- Hereditary breast and ovarian cancer syndrome
- Cowden Syndrome
- Li-Fraumeni syndrome
- Nijmegen Syndrome
- Peutz-Jeghers syndrome
- Pancreatic cancer/melanoma syndrome
- Juvenile Polyposis Syndrome
- Hereditary Prostate Cancer
- Hereditary diffuse gastric cancer
- Gliome
- Melanome
- Type 1 Neurofibromathose
- Familial adenomatous polyposis
- Polyposis associated with MUTYH
- Associated adenomatous polyposis POLD1 and POLE
- Hereditary mixed polyposis syndrome
- BAP1-associated tumor predisposition syndrome
- Identifies variants in 40 genes related to cancer and hereditary cancer syndromes.
- A genetic counsellor approved by medmesafe will accompany you before and after the analysis by video consultation.
Download results report
8 weeks
Spain
Saliva
Whole Exome Secuencing
- Counting from the reception of the sample in the laboratory.
- Only available in Spain at the moment
- Collection of saliva.
- Whole exome sequencing (WES) with illumina platform (HiSeq X10, NovaSeq 6000).
- Average coverage 110x sequencing >97% at ≥20x.
- Compliant with the Laboratory Developed Test (LDT) regulations and performed in a CLIA-certified laboratory (CLIA#22D2089381)
- CAP Accreditation (College of American Pathologists).
- All the reports are reviewed by an expert medical team with more than 10 years of experience in Whole Genome and Exome sequencing, including members of the Personal Genome Project of Harvard Medical School.
- Possible outcomes:
- Pathogenic variants, probably pathogenic variants and variants of uncertain significance (VOUS) are reported.
- Technical limitations:
- Inversions and complex structural rearrangements such as translocations are not detected.
- For regions of high homology, del/dup analysis is not performed.
- Copy number variants in APC, ATM, CHEK2, GREM1, MSH6, PALB2, PMS2, PTEN, STK11, and TP53 are detected at multi-exon resolution (2 or more exons).
- EPCAM variant detection is limited to del/dup analysis of the 3’ end of the gene.
- The genes included are associated with several cancer types, however there may be other genes associated with hereditary cancer that are not covered by this panel.
- No secondary findings are reported outside the established panel.
Testimonials
Rod Paley
Graeme McKenzie
Daniel Crigan
The analysis detects 40 genes related to different types of cancer".
Multi-gene analysis is more effective than single gene/type cancer testing, as it detects a greater number of people at risk".
The report of the test results will help the doctor decide the best course of action for each case".
- To find out if your genes determine that you are at risk for these cancers.
- If you have one, it is recommended to know if it will be transmitted to your descendants and to personalize the treatments.
- If you have a family history of cancer diagnosed before age 50.
- If there are diagnoses of cancer in different family members and in different generations.
- If you have several types of tumors.
- If you have cancer, in order to know its possible hereditary character.
- If a pattern of cancer typical of certain hereditary predispositions is present in your family (ex: colorectal and endometrial cancer in the Lynch Syndrome).
How does it work?
-
Select desired analysis and a specialist, then you have a video-consultation. -
Receive a sample collector kit at home that will be picked up by a courier. -
One of our partner labs makes the analysis. -
Your healthcare professional presents your results via videoconference.
You can help by sharing this information with your contacts or doctor
